Jiangsu Enhua Pharmaceutical Co., Ltd. is a pharmaceutical group company integrating science, industry and trade. It is a key high-tech enterprise under the National Torch Plan, an international environmental management system certification enterprise, and the vice president of the China Narcotic Drugs Association. Unit, Vice President Unit of Jiangsu Pharmaceutical Industry Association.
The company has a production center, technology center, marketing center, three pharmaceutical subsidiaries and two commercial companies. The company currently has more than 5,200 employees, of whom 52% are college graduates or above.
In 2006, the sales volume ranked first in the intravenous anesthetic market, and the sales volume ranked second in the intravenous anesthetic market. The company is a key high-tech enterprise under the National Torch Plan and a designated manufacturer of psychotropic drugs by the State Food and Drug Administration. The "Enhua" trademark has been rated as a famous trademark in Jiangsu Province. The company's advantages in integrating pharmaceutical production, research and development, transportation, and sales, as well as the high gross profit margin in the production of central nervous system APIs, have laid a good foundation for the company's future development.
The company has built two large-scale pharmaceutical GMP production bases for raw materials and preparations, covering a total area of ??more than 600 acres. The company has API workshops, solid preparation workshops, water injection workshops, freeze-dried powder injection workshops that are certified by the state and meet GMP standards, and has more than ten automated production lines for tablets, capsules, water injections, powder injections, and granules. Currently, it has 22 kinds of raw materials with an annual output of 550 tons; and more than 90 kinds of western medicine preparations. It has the production capacity of 1 billion tablets/year of solid preparations and 10 million injections/year.
The company’s main products are central nervous system drug preparations and raw materials. The main categories include anesthesia, psychiatric and neurological. Products are used in the treatment of anesthesia, sedation, analgesia, antipsychotics, anti-anxiety/depression, anti-epilepsy and other diseases; through years of unremitting efforts in product development, production and service, the company has established a complete range of central nervous system drug products series and marketing network.
Jiangsu Enhua Pharmaceutical Co., Ltd. is a joint-stock company established by Jiangsu Enhua Pharmaceutical Group Co., Ltd. based on the overall change of the audited book net assets as of December 31, 2006. On April 29, 2007, the company was approved and registered with the Xuzhou Industrial and Commercial Bureau in accordance with the law, and received the "Enterprise Legal Person Business License" with a registration number. The company has a registered capital of 90 million yuan, a face value of RMB 1.00 per share, and the legal representative is Sun Pengsheng.